Drugs / DR-2041
last change Sep 2007 re-read 3 minutes ago

DR-2041

Developed for
premature menopause
Investigated by
Duramed Research

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00361569 Aug 2006 → Sep 2007 premature menopause Duramed Research Completed Met primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DR-2041 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00361569 ↗